Independent Nephrology Services Charlotte is a medicare approved dialysis facility center in Charlotte, North Carolina and it has 10 dialysis stations. It is located in Mecklenburg county at 8430 University Executive Park Dr Ste 690, Charlotte, NC, 28262. You can reach out to the office of Independent Nephrology Services Charlotte at (704) 717-2825. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Independent Nephrology Services Charlotte has the following ownership type - Profit. It was first certified by medicare in June, 2007. The medicare id for this facility is 342655 and it accepts patients under medicare ESRD program.
| Name | Independent Nephrology Services Charlotte |
|---|---|
| Location | 8430 University Executive Park Dr Ste 690, Charlotte, North Carolina |
| No. of Dialysis Stations | 10 |
| Medicare ID | 342655 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 8430 University Executive Park Dr Ste 690, Charlotte, North Carolina, 28262 | |
| (704) 717-2825 | |
News Archive
Alnara Pharmaceuticals, Inc., a pharmaceutical company developing non-systemic, orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that it has secured $35 million in Series B venture capital financing. The round was led by new investor MPM Capital, joined by current investors Third Rock Ventures, Frazier Healthcare and Bessemer Venture Partners. In conjunction with the MPM investment, managing director Ashley Dombkowski, Ph.D., will join Alnara's board of directors.
New research shows that multiple sclerosis (MS) activity can increase during spring and summer months. The research is published in the August 31, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.
Ever since the German midfielder, Christoph Kramer suffered a black-out in the final of the 2014 Football World Cup there has been a growing number of debates around the question of sport-related concussion. The emphasis here is on correct diagnosis. There are plenty of symptoms but these can be ambiguous.
Researchers have discovered a key protein that controls how stem cells "choose" to become either skeletal muscle cells that move limbs, or smooth muscle cells that support blood vessels, according to a study published in the Proceedings of the National Academy of Sciences (PNAS).
› Verified 9 days ago
| NPI Number | 1316905730 |
| Organization Name | Ins-charlotte |
| Doing Business As | Independent Nephrology Services, Inc. |
| Address | 8430 University Exec Park Dr Charlotte, North Carolina, 28262 |
| Phone Number | (704) 717-2825 |
News Archive
Alnara Pharmaceuticals, Inc., a pharmaceutical company developing non-systemic, orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that it has secured $35 million in Series B venture capital financing. The round was led by new investor MPM Capital, joined by current investors Third Rock Ventures, Frazier Healthcare and Bessemer Venture Partners. In conjunction with the MPM investment, managing director Ashley Dombkowski, Ph.D., will join Alnara's board of directors.
New research shows that multiple sclerosis (MS) activity can increase during spring and summer months. The research is published in the August 31, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.
Ever since the German midfielder, Christoph Kramer suffered a black-out in the final of the 2014 Football World Cup there has been a growing number of debates around the question of sport-related concussion. The emphasis here is on correct diagnosis. There are plenty of symptoms but these can be ambiguous.
Researchers have discovered a key protein that controls how stem cells "choose" to become either skeletal muscle cells that move limbs, or smooth muscle cells that support blood vessels, according to a study published in the Proceedings of the National Academy of Sciences (PNAS).
› Verified 9 days ago
| Dialysis patients with Hemoglobin data | 7 |
News Archive
Alnara Pharmaceuticals, Inc., a pharmaceutical company developing non-systemic, orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that it has secured $35 million in Series B venture capital financing. The round was led by new investor MPM Capital, joined by current investors Third Rock Ventures, Frazier Healthcare and Bessemer Venture Partners. In conjunction with the MPM investment, managing director Ashley Dombkowski, Ph.D., will join Alnara's board of directors.
New research shows that multiple sclerosis (MS) activity can increase during spring and summer months. The research is published in the August 31, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.
Ever since the German midfielder, Christoph Kramer suffered a black-out in the final of the 2014 Football World Cup there has been a growing number of debates around the question of sport-related concussion. The emphasis here is on correct diagnosis. There are plenty of symptoms but these can be ambiguous.
Researchers have discovered a key protein that controls how stem cells "choose" to become either skeletal muscle cells that move limbs, or smooth muscle cells that support blood vessels, according to a study published in the Proceedings of the National Academy of Sciences (PNAS).
› Verified 9 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular peritoneal dialysis at the center | 21 |
| Adult patient months included in Kt/V greater than or equal to 1.7 | 155 |
| Percentage of adult patients getting regular peritoneal dialysis at the center | 99 |
| Percentage of pediatric patients getting regular peritoneal dialysis at the center |
News Archive
Alnara Pharmaceuticals, Inc., a pharmaceutical company developing non-systemic, orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that it has secured $35 million in Series B venture capital financing. The round was led by new investor MPM Capital, joined by current investors Third Rock Ventures, Frazier Healthcare and Bessemer Venture Partners. In conjunction with the MPM investment, managing director Ashley Dombkowski, Ph.D., will join Alnara's board of directors.
New research shows that multiple sclerosis (MS) activity can increase during spring and summer months. The research is published in the August 31, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.
Ever since the German midfielder, Christoph Kramer suffered a black-out in the final of the 2014 Football World Cup there has been a growing number of debates around the question of sport-related concussion. The emphasis here is on correct diagnosis. There are plenty of symptoms but these can be ambiguous.
Researchers have discovered a key protein that controls how stem cells "choose" to become either skeletal muscle cells that move limbs, or smooth muscle cells that support blood vessels, according to a study published in the Proceedings of the National Academy of Sciences (PNAS).
› Verified 9 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Independent Nephrology Services Charlotte with elevated calcium levels.
| Patients with hypercalcemia | 21 |
| Hypercalcemia patient months | 155 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 6 |
| Patients with Serumphosphor | 24 |
| Patients with Serumphosphor less than 3.5 mg/dL | 5 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 24 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 37 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 14 |
| Patients with Serumphosphor greater than 7 mg/dL | 20 |
News Archive
Alnara Pharmaceuticals, Inc., a pharmaceutical company developing non-systemic, orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that it has secured $35 million in Series B venture capital financing. The round was led by new investor MPM Capital, joined by current investors Third Rock Ventures, Frazier Healthcare and Bessemer Venture Partners. In conjunction with the MPM investment, managing director Ashley Dombkowski, Ph.D., will join Alnara's board of directors.
New research shows that multiple sclerosis (MS) activity can increase during spring and summer months. The research is published in the August 31, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.
Ever since the German midfielder, Christoph Kramer suffered a black-out in the final of the 2014 Football World Cup there has been a growing number of debates around the question of sport-related concussion. The emphasis here is on correct diagnosis. There are plenty of symptoms but these can be ambiguous.
Researchers have discovered a key protein that controls how stem cells "choose" to become either skeletal muscle cells that move limbs, or smooth muscle cells that support blood vessels, according to a study published in the Proceedings of the National Academy of Sciences (PNAS).
› Verified 9 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 13 |
| Hospitalization Rate in facility | 256.2 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 635.8 |
| Hospitalization Rate: Lower Confidence Limit | 110.9 |
News Archive
Alnara Pharmaceuticals, Inc., a pharmaceutical company developing non-systemic, orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that it has secured $35 million in Series B venture capital financing. The round was led by new investor MPM Capital, joined by current investors Third Rock Ventures, Frazier Healthcare and Bessemer Venture Partners. In conjunction with the MPM investment, managing director Ashley Dombkowski, Ph.D., will join Alnara's board of directors.
New research shows that multiple sclerosis (MS) activity can increase during spring and summer months. The research is published in the August 31, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.
Ever since the German midfielder, Christoph Kramer suffered a black-out in the final of the 2014 Football World Cup there has been a growing number of debates around the question of sport-related concussion. The emphasis here is on correct diagnosis. There are plenty of symptoms but these can be ambiguous.
Researchers have discovered a key protein that controls how stem cells "choose" to become either skeletal muscle cells that move limbs, or smooth muscle cells that support blood vessels, according to a study published in the Proceedings of the National Academy of Sciences (PNAS).
› Verified 9 days ago
The rate of readmission show you whether patients who were being treated regularly at Independent Nephrology Services Charlotte were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 22.3 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 53.4 |
| Readmission Rate: Lower Confidence Limit | 5.4 |
News Archive
Alnara Pharmaceuticals, Inc., a pharmaceutical company developing non-systemic, orally-delivered protein therapeutics for the treatment of metabolic diseases, announced today that it has secured $35 million in Series B venture capital financing. The round was led by new investor MPM Capital, joined by current investors Third Rock Ventures, Frazier Healthcare and Bessemer Venture Partners. In conjunction with the MPM investment, managing director Ashley Dombkowski, Ph.D., will join Alnara's board of directors.
New research shows that multiple sclerosis (MS) activity can increase during spring and summer months. The research is published in the August 31, 2010, issue of Neurology, the medical journal of the American Academy of Neurology.
Ever since the German midfielder, Christoph Kramer suffered a black-out in the final of the 2014 Football World Cup there has been a growing number of debates around the question of sport-related concussion. The emphasis here is on correct diagnosis. There are plenty of symptoms but these can be ambiguous.
Researchers have discovered a key protein that controls how stem cells "choose" to become either skeletal muscle cells that move limbs, or smooth muscle cells that support blood vessels, according to a study published in the Proceedings of the National Academy of Sciences (PNAS).
› Verified 9 days ago